mTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4(+)CD57(+) T Cells In Vivo and In Vitro

Calcineurin inhibitors have improved graft survival in solid-organ transplantation but their use is limited by toxicity, requiring a switch to another immunosuppressor in some cases. Belatacept is one option that has been shown to improve graft and patient survival despite being associated with a hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Herr, Florence, Dekeyser, Manon, Le Pavec, Jerome, Desterke, Christophe, Chiron, Andrada-Silvana, Bargiel, Karen, Mercier, Olaf, Vernochet, Amelia, Fadel, Elie, Durrbach, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142381/
https://www.ncbi.nlm.nih.gov/pubmed/37111784
http://dx.doi.org/10.3390/pharmaceutics15041299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142381/
https://www.ncbi.nlm.nih.gov/pubmed/37111784
http://dx.doi.org/10.3390/pharmaceutics15041299

Ejemplares similares